Search
12/02/2024
Has fluoroless endourology (URS and PCNL) come of age? Evidence from a comprehensive literature review
Massella V., Pietropaolo A., Gauhar V., Emiliani E., Somani B.K.. Has fluoroless endourology (URS and PCNL) come of age? Evidence from a comprehensive literature review. Actas Urologicas Espanolas. 2024; 48(1)DOI:10.1016/j.acuro.2023.04.003. PMID:. IF:(Q/D).
12/02/2024
Kidney stones in renal transplant recipients: A systematic review.
Piana A, Basile G, Masih S, Bignante G, Uleri A, Gallioli A, Prudhomme T, Boissier R, Pecoraro A, Campi R, Di Dio M, Alba S, Breda A, Territo A. Kidney stones in renal transplant recipients: A systematic review.. Actas Urologicas Espanolas. 2024; 48(1)DOI:10.1016/j.acuroe.2023.08.003. PMID:37574010. IF:(Q/D).
12/02/2024
Kidney stones in renal transplant recipients: A systematic review
Piana A., Basile G., Masih S., Bignante G., Uleri A., Gallioli A., Prudhomme T., Boissier R., Pecoraro A., Campi R., Di Dio M., Alba S., Breda A., Territo A.. Kidney stones in renal transplant recipients: A systematic review. Actas Urologicas Espanolas. 2024; 48(1)DOI:10.1016/j.acuro.2023.07.003. PMID:. IF:(Q/D).
12/02/2024
Intrarenal Venous Flow Pattern Changes Do Relate With Renal Function Alterations in Acute Heart Failure.
de la Espriella R, Núñez-Marín G, Cobo M, de Castro Campos D, Llácer P, Manzano L, Zegrí I, Rodriguez-Pérez Á, Santas E, Lorenzo M, Miñana G, Núñez E, Górriz JL, Bayés-Genís A, Fudim M, Mullens W, Núñez J. Intrarenal Venous Flow Pattern Changes Do Relate With Renal Function Alterations in Acute Heart Failure.. JACC-Heart Failure. 2024; 12(2)DOI:10.1016/j.jchf.2023.07.015. PMID:37676214. IF:11.800(Q1/1D).
12/02/2024
The role of sex and gender in the diagnosis and treatment of lung cancer: the 6th ICAPEM Annual Symposium.
Viñolas N, Mezquita L, Corral J, Cobo M, Gil-Moncayo F, Paz-Ares L, Remon J, Rodríguez M, Ruano-Raviña A, Conde E, Majem M, Garrido P, Felip E, Isla D, de Castro J. The role of sex and gender in the diagnosis and treatment of lung cancer: the 6th ICAPEM Annual Symposium.. Clinical & Translational Oncology. 2024; 26(2)DOI:10.1007/s12094-023-03262-x. PMID:37490262. IF:2.500(Q3/6D).
12/02/2024
Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial.
Ribera JM, Morgades M, Garcia-Calduch O, Sirvent M, Buendia B, Cervera M, Luzardo H, Hernandez-Rivas JM, Sitges M, Garcia-Cadenas I, Abrisqueta P, Montesinos P, Bastos-Oreiro M, De Llano MQ, Bravo P, Torrent A, Herrera P, Garcia-Guinon A, Vall-Llovera F, Serrano J, Terol MJ, Bergua JM, Garcia-Noblejas A, Barrenetxea C, Llorente L, Garcia-Belmonte D, Gimeno E, Cladera A, Mercadal S, Sancho JM. Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial.. HAEMATOLOGICA. 2024; 109(2)DOI:10.3324/haematol.2023.283342. PMID:37560813. IF:10.100(Q1/2D).